Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 4/2008

01-12-2008 | Editorial

Pheochromocytoma: Time to Stamp Out “Malignancy”?

Author: Arthur S. Tischler

Published in: Endocrine Pathology | Issue 4/2008

Login to get access

Excerpt

Pheochromocytomas and extra-adrenal paragangliomas are slowly growing but potentially lethal tumors that can metastasize widely or extensively invade local structures. Patients with unresectable tumors have a poor prognosis, with death often occurring as a result of uncontrolled catecholamine secretion. …
Literature
1.
Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11:423–36, 2004.PubMedCrossRef
2.
DeLellis RA, Lloyd RV, Heitz PU, Eng C. Tumours of endocrine organs. In World Health Organization Classification of Tumors. Lyon: IARC, 2004.
3.
Lack EE. Tumors of the adrenal gland and extraadrenal paraganglia. Washington, DC: American Registry Of Pathology, 2007.
4.
Goldstein RE, O'Neill JA Jr., Holcomb GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755–64, 1999 discussion 764-6.PubMedCrossRef
Metadata
Title
Pheochromocytoma: Time to Stamp Out “Malignancy”?
Author
Arthur S. Tischler
Publication date
01-12-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 4/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9047-x

Other articles of this Issue 4/2008

Endocrine Pathology 4/2008 Go to the issue

OriginalPaper

Immunohistochemical Analysis of 11-β-Hydroxysteroid Dehydrogenase Type 2 and Glucocorticoid Receptor in Subclinical Cushing’s Disease due to Pituitary Macroadenoma

ReviewPaper

A Diagnostic Approach to Adrenal Cortical Lesions

ReviewPaper

Adrenal Cystic Lesions: A Clinicopathological Analysis of 25 Cases with Proposed Histogenesis and Review of the Literature

OriginalPaper

Expression of Wnt4 in Human Pituitary Adenomas Regulates Activation of the β-Catenin-Independent Pathway

ReviewPaper

Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining

REVIEW

Challenging Lesions in the Differential Diagnosis of Endocrine Tumors: Parathryoid Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits